https://doctransparency.com/doctor/tx/houston/arvind-bhimaraj-1275864878
Medicare Enrolled

Dr. Arvind Bhimaraj, M.D.,

Cardiovascular Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
6550 FANNIN ST, Houston, TX 77030
7134411100
In practice since 2010 (16 years)
NPI: 1275864878 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bhimaraj from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhimaraj? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bhimaraj

Dr. Arvind Bhimaraj is a cardiovascular disease in Houston, TX, with 16 years in practice. Based on federal Medicare data, Dr. Bhimaraj performed 457 Medicare services across 252 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bhimaraj received a total of $193,918 from 36 pharmaceutical and/or device companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bhimaraj is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ 457 Medicare services$ $193,918 industry payments

Medicare Practice Summary

Medicare Utilization ↗
457
Medicare services
Bottom 15% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
252
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity194$95$302
Office visit, established patient (30-39 min)101$98$314
Critical care, first 30-74 min60$173$672
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes35$10$64
Hospital follow-up visit, moderate complexity31$62$211
Insertion of tube in right heart chambers for measurement13$100$608
Initial hospital admission, moderate complexity12$105$401
New patient office visit (45-59 min)11$135$483
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$193,918
Total received (2018-2024)
Avg $27,703/year across 7 years
Top 3% in TX for cardiovascular disease
36
Companies
616
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$90,246 (46.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$62,321 (32.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$41,351 (21.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$35,177
2023
$17,688
2022
$12,422
2021
$58,450
2020
$12,552
2019
$38,296
2018
$19,333

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$95,661
AstraZeneca Pharmaceuticals LP
$52,187
ABIOMED
$29,323
Getinge USA Sales, LLC
$5,445
SANOFI-AVENTIS U.S. LLC
$4,572
Impulse Dynamics (USA) Inc.
$1,253
CVRx, Inc.
$1,015
Alnylam Pharmaceuticals Inc.
$811
Medtronic Vascular, Inc.
$519
Paragonix Technologies, Inc.
$421
Amgen Inc.
$333
Boston Scientific Corporation
$278
AtriCure, Inc.
$216
Novartis Pharmaceuticals Corporation
$202
Medtronic, Inc.
$174
Actelion Pharmaceuticals US, Inc.
$153
Inari Medical, Inc.
$140
Datascope Corp.
$132
PFIZER INC.
$131
Respicardia, Inc.
$123
ATRICURE, INC.
$108
Silk Road Medical, Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Pulmonx Corporation
$92
Janssen Pharmaceuticals, Inc
$80
KAMADA LTD.
$76
Bayer HealthCare Pharmaceuticals Inc.
$50
SCPHARMACEUTICALS INC.
$44
Relypsa, Inc.
$35
PORTOLA PHARMACEUTICALS, INC.
$26
Lexicon Pharmaceuticals, Inc.
$25
Daiichi Sankyo Inc.
$25
Haemonetics Corporation
$24
E.R. Squibb & Sons, L.L.C.
$19
Gilead Sciences, Inc.
$16
Tactile Systems Technology Inc
$14
Top 3 companies account for 91.4% of total payments
Associated products mentioned in payments ›
2ND GEN CENTRIMAG PRIMARY CONSOLE · AMVUTTRA · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · Adempas · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIOSAVE HYBRID · CHANTIX · CHARTIS CATHETER · COREVALVE EVOLUT R · CRM-Research only · CYTOGAM · CardioMEMS HF System · Cardiohelp · CentriMag · Circulatory Support · Corlanor · ELIQUIS · EMBLEM · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · Endurant · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL STRUCTURAL HEART · GENERAL VASCULAR INTERVENTION · GENERAL - VASCULAR INTERVENTION · HEARTMATE TOUCH · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate II LVAS · HeartMate Touch · HeartWare HVAD · INJECTAFER · Impella · Inpefa · JARDIANCE · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · Pacemakers · Proclaim Family of SCS IPGs · RHYTHMIA · Repatha · S · SYNERGY ABLATION SYSTEM · SherpaPak · TEG · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · THYMOGLOBULIN · TYPE B PLUG · UPTRAVI · VIGILANT · VYNDAQEL · Vasoview Hemopro 2 · Veltassa · WAINUA · WATCHMAN · XARELTO · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (46%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for cardiovascular disease in TX.

Equivalent to $42,433 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bhimaraj is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 3%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bhimaraj experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bhimaraj performed 194 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhimaraj receive payments from pharmaceutical companies?
Yes. Dr. Bhimaraj received a total of $193,918 from 36 companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhimaraj's costs compare to other cardiovascular diseases in Houston?
Dr. Bhimaraj's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhimaraj) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →